New drug-pricing policy weighing on local pharmaceutical market

The current positive list system is weighing on the domestic pharmaceutical manufacturers as the new system will fatally damage their earnings, experts said.

Under the new system, when the patent period of an original drug expires, its price will be decreased by 20 percent and the price of the corresponding generic drug, which is currently 80 percent of the original drug, will be decreased t...